This list should include a brief description of the aid along with its value. In the case of substantial material assistance whose value is difficult to estimate, its description should include the characteristic of the benefits received by the patients’ organization.
This information is published on the website of the local pharmaceutical company, and in the absence thereof, on its global website or on the INFARMA website. According to the Code, this information should be updated at least once a year.
| Support granted to patients' organizations by INFARMA member |
|---|
| ABBVIE Polska Sp. z o.o. |
| ACTELLION Pharma Polska Sp. z o.o. |
| ALLERGAN Sp. z o.o. |
| ALMIRALL Sp. z o.o. |
| AMGEN BIOTECHNOLOGIA Sp. z o.o. |
| ASTELLAS PHARMA Sp. z o.o. |
| ASTRAZENECA PHARMA POLAND Sp. z o.o. |
| BAYER Sp. z o.o. |
| BIOGEN POLAND Sp. z o.o. |
| BOEHRINGER INGELHEIM MARKETING Sp. z o.o. |
| BRISTOL – MYERS SQUIBB POLSKA Sp. z o.o. |
| CELGENE Sp. z o.o. |
| CHIESI POLAND Sp. z o.o. |
| ELI LILLY POLSKA Sp. z o.o. |
| GSK COMMERCIAL Sp. z o.o. |
| IPSEN POLAND Sp. z o.o. |
| JANSSEN-CILAG POLSKA Sp. z o.o. |
| LUNDBECK POLAND Sp. z o.o. |
| MERCK Sp. z o.o. |
| MSD POLSKA Sp. z o.o. |
| NOVARTIS POLAND Sp. z o.o. |
| NOVO NORDISK PHARMA Sp. z o.o. |
| PFIZER POLSKA Sp. z o.o. |
| PIERRE FABRE MEDICAMENT POLSKA Sp. z o.o. |
| ROCHE POLSKA Sp. z o.o. |
| SANOFI PASTEUR Sp. z o.o. nie dotyczy - nie było wsparcia w 2018 |
| SANOFI-AVENTIS Sp. z o.o. |
| SERVIER POLSKA SP. z o.o. |
| TAKEDA Polska Sp. z o.o. |
| UCB PHARMA Sp. z o.o. |
